# US 2003/0228700 A1 · Labeling reagent and methods of use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0228700 A1
- Document ID: US20030228700A1
- Status: Published application
- Kind: A1
- Application number: 10/289,009
- Filed: 2002-11-05
- Published: 2003-12-11
- Earliest claimed: 2001-11-05
- Assignees: Irm LLC
- Inventors: Eric C. Peters; Ansgar Brock; Christer Ericson
- Web page: https://patentgrep.com/patent/US20030228700A1

## CPC

- C07K 1/13: Labelling of peptides
- C07K 14/805: Haemoglobins; Myoglobins
- G01N 33/6848: {Methods of protein analysis involving mass spectrometry}
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- H01J 49/0027: {Methods for using particle spectrometers}
- H01J 49/38: Omegatrons {; using ion cyclotron resonance}
- G01N 2035/00158: {Elements containing microarrays, i.e. "biochip"}
- G01N 2458/15: Non-radioactive isotope labels, e.g. for detection by mass spectrometry
- G16B 50/00: ICT programming tools or database systems specially adapted for bioinformatics
- H01J 49/00: Particle spectrometers or separator tubes
- Y10T 436/24: Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- H01J: ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS (spark-gaps H01T; electric arc lamps H05B31/00; particle accelerators H05H)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The present invention provides compounds which are useful as multifunctional labels in proteomics studies. The labels of the present invention are both lysine specific and increase the overall sequence coverage obtained in polypeptide mapping experiments, by for example, increasing the ionization efficiencies of lysine-terminated tryptic fragments. In certain aspects, the labels of the present invention can be used to measure differential quantitation, as for example, deuterium(s) can easily be introduced during their synthesis. In one aspect, a C-terminal derivatized lysine biases the fragment ion intensities strongly toward C-terminal fragment ions, resulting in a highly simplified tandem mass spectrum. In further aspects, the number of lysine residues can be determined in a polypeptide.

## Claims

### Claim 1

A polypeptide having a modified lysine residue of Formula I:
21
wherein each R is independently a member selected from the group consisting of hydrogen, deuterium, halogen, hydroxyl, cyano, optionally substituted alkyl, optionally substituted alkylcarbamoyl, optionally substituted alkoxy, optionally substituted alkoxycarbonyl, optionally substituted aryl, optionally substituted aryloxy, optionally substituted aryloxycarbonyl, optionally substituted arylcarbamoyl, optionally substituted siloxanly and an affinity tag;
mis0-7;and
wherein the circle joining the two nitrogens represents an optionally substituted monocyclic or bicyclic ring system having between 2 and 12 additional ring atoms, and wherein said ring atoms are each selected from the group consisting of carbon, oxygen, nitrogen, sulfur and silicon.

### Claim 2 (depends on 1)

The polypeptide having a modified lysine residue according to claim 1, wherein said optionally substituted monocyclic or bicyclic ring system is selected from the group consisting of imidozolinyl, imidazolindinyl, pyrimidinyl, imidazolyl, purinyl, quanazolinyl and pteridinyl.

### Claim 3 (depends on 1)

The polypeptide having a modified lysine residue according to claim 1, said polypeptide having Formula Ia:
22
wherein R1, R2, R3 and R4 are each independently a member selected from the group consisting of hydrogen, deuterium, halogen, hydroxyl, cyano, optionally substituted alkyl, optionally substituted alkylcarbamoyl, optionally substituted alkoxy, optionally substituted alkoxycarbonyl, optionally substituted aryl, optionally substituted aryloxy, optionally substituted aryloxycarbonyl, optionally substituted arylcarbamoyl and an affinity tag; or, alternatively, R2, R3 and the carbons to which they are attached join to form an n-membered carbocyclic, heterocyclic, aryl or heteroaryl ring;
n is about 4 to about 8;
R5 is a member selected from the group consisting of hydrogen, halogen, hydroxyl, optionally substituted alkyl, optionally substituted alkoxy, optionally substituted aryl and an affinity tag; and
y is 0, 1 or 2.

### Claim 4 (depends on 1)

The polypeptide having a modified lysine residue according to claim 1, said polypeptide having Formula Ib:
23
wherein R1, R2, R3 and R4 are each independently a member selected from the group consisting of hydrogen, deuterium, halogen, hydroxyl, cyano, optionally substituted alkyl, optionally substituted alkylcarbamoyl, optionally substituted alkoxy, optionally substituted alkoxycarbonyl, optionally substituted aryl, optionally substituted aryloxy, optionally substituted aryloxycarbonyl, optionally substituted arylcarbamoyl and an affinity tag; or, alternatively, R2, R3 and the carbons to which they are attached join to form an n-membered carbocyclic, heterocyclic, aryl or heteroaryl ring;
n is about 4 to about 8; and
R5is a member selected from the group consisting of hydrogen, halogen, hydroxyl, optionally substituted alkyl, optionally substituted alkoxy, optionally substituted aryl and an affinity tag.

### Claim 5 (depends on 1)

The polypeptide having a modified lysine residue according to claim 1, wherein R1, R2, R3, R4 and R5 are each hydrogen.

### Claim 6 (depends on 1)

The polypeptide having a modified lysine residue according to claim 1, wherein R1, R2, R3, R4 and R5 are each deuterium.

### Claim 7 (depends on 1)

The polypeptide having a modified lysine residue according to claim 1, wherein R1 and R2 are each alkyl.

### Claim 8 (depends on 1)

The polypeptide having a modified lysine residue according to claim 1, wherein R1 and R2 are each independently a member selected from the group consisting of methyl, ethyl, propyl and butyl.

### Claim 9

A compound of Formula II:
24
wherein each R is independently a member selected from the group consisting of hydrogen, deuterium, halogen, hydroxyl, cyano, optionally substituted alkyl, optionally substituted alkylcarbamoyl, optionally substituted alkoxy, optionally substituted alkoxycarbonyl, optionally substituted aryl, optionally substituted aryloxy, optionally substituted aryloxycarbonyl, optionally substituted arylcarbamoyl, optionally substituted siloxanly and an affinity tag;
m is 0-7;
wherein the circle joining the two nitrogens represents an optionally substituted monocyclic or bicyclic ring system having between 2 and 12 additional ring atoms, and wherein said ring atoms are each selected from the group consisting of carbon, oxygen, nitrogen, sulfur and silicon; and
LG is a leaving group.

### Claim 10 (depends on 9)

The compound of claim 9, wherein said LG is selected from the group consisting of a halogen, an alkoxy group, an alkylthio group, an aryloxy group, a tosyl group and an arylthio group.

### Claim 11 (depends on 9)

The compound of claim 9, wherein said compound is of the formula IIa
25
wherein R1, R2, R3 and R4 are each independently a member selected from the group consisting of hydrogen, deuterium, halogen, hydroxyl, cyano, optionally substituted alkyl, optionally substituted alkylcarbamoyl, optionally substituted alkoxy, optionally substituted alkoxycarbonyl, optionally substituted aryl, optionally substituted aryloxy, optionally substituted aryloxycarbonyl, optionally substituted arylcarbamoyl and an affinity tag; or, alternatively, R2, R3 and the carbons to which they are attached join to form an n-membered carbocyclic, heterocyclic, aryl or heteroaryl ring;
n is about 4 to about 8;
R5 is a member selected from the group consisting of hydrogen, halogen, hydroxyl, optionally substituted alkyl, optionally substituted alkoxy, optionally substituted aryl and an affinity tag;
LG is X-CH3, wherein X is a heteroatom selected from the groups consisting of O and S; and
y is 0, 1 or 2.

### Claim 12 (depends on 11)

The compound of claim 11, wherein said compound is of the formula IIb:
26
wherein R1, R2, R3 and R4 are each independently a member selected from the group consisting of hydrogen, deuterium, halogen, hydroxyl, cyano, optionally substituted alkyl, optionally substituted alkylcarbamoyl, optionally substituted alkoxy, optionally substituted alkoxycarbonyl, optionally substituted aryl, optionally substituted aryloxy, optionally substituted aryloxycarbonyl, optionally substituted arylcarbamoyl and an affinity tag; or, alternatively, R2, R3 and the carbons to which they are attached join to form an n-membered carbocyclic, heterocyclic, aryl or heteroaryl ring;
n is about 4 to about 8;
R5 is a member selected from the group consisting of hydrogen, halogen, hydroxyl, optionally substituted alkyl, optionally substituted alkoxy, optionally substituted aryl and an affinity tag; and
LG is X-CH3, wherein X is a heteroatom selected from the groups consisting of O and S.

### Claim 13 (depends on 12)

The compound according to claim 12, wherein R1, R2, R3, R4 and R5 are each hydrogen.

### Claim 14 (depends on 12)

The compound according to claim 12, wherein R1, R2, R3, R4 and R5 are each deuterium.

### Claim 15 (depends on 12)

The compound according to claim 12, wherein R1 and R2 are each alkyl.

### Claim 16 (depends on 12)

The compound according to claim 12, wherein R1 and R2 arc each independently a member selected from the group consisting of methyl, ethyl, propyl and butyl.

### Claim 17 (depends on 12)

The compound according to claim 12, wherein R2 and R3 and the carbons to which they are attached join to form a 6-member carbocyclic ring.

### Claim 18 (depends on 12)

The compound according to claim 12, wherein R5 is a methyl group.

### Claim 19 (depends on 12)

The compound according to claim 12, wherein R5 is benzoic acid.

### Claim 20 (depends on 12)

The compound according to claim 12, wherein R1 comprises an affinity tag.

### Claim 21

A method of derivatizing a polypeptide having a lysine residue, said method comprising:
incubating said polypeptide having a lysine residue with a compound of Formula II to form a polypeptide with a lysine residue of Formula I:
27
wherein each R is independently a member selected from the group consisting of hydrogen, deuterium, halogen, hydroxyl, cyano, optionally substituted alkyl, optionally substituted alkylcarbamoyl, optionally substituted alkoxy, optionally substituted alkoxycarbonyl, optionally substituted aryl, optionally substituted aryloxy, optionally substituted aryloxycarbonyl, optionally substituted arylcarbamoyl, optionally substituted siloxanly and an affinity tag;
mis0-7;and
wherein the circle joining the two nitrogens represents an optionally substituted monocyclic or bicyclic ring system having between 2 and 12 additional ring atoms, and wherein said ring atoms are each selected from the group consisting of carbon, oxygen, nitrogen, sulfur and silicon, thereby derivatizing said polypeptide having a lysine residue.

### Claim 22 (depends on 21)

The method of derivatizing a polypeptide according to claim 21, wherein said polypeptide has Formula Ia:
28
wherein R1, R2, R3 and R4 are each independently a member selected from the group consisting of hydrogen, deuterium, halogen, hydroxyl, cyano, optionally substituted alkyl, optionally substituted alkylcarbamoyl, optionally substituted alkoxy, optionally substituted alkoxycarbonyl, optionally substituted aryl, optionally substituted aryloxy, optionally substituted aryloxycarbonyl, optionally substituted arylcarbamoyl and an affinity tag; or, alternatively, R2, R3 and the carbons to which they are attached join to form an n-membered carbocyclic, heterocyclic, aryl or heteroaryl ring;
n is an integer from about 4 to about 8;
R5 is a member selected from the group consisting of hydrogen, halogen, hydroxyl, optionally substituted alkyl, optionally substituted alkoxy, optionally substituted aryl and an affinity tag; and
y is 0, 1 or2.

### Claim 23 (depends on 22)

The method of derivatizing a polypeptide according to claim 22, wherein said polypeptide has Formula Ib:
29

### Claim 24 (depends on 22)

The method of derivatizing a polypeptide according to claim 22, wherein R1, R2, R3, R4 and R5 are each hydrogen.

### Claim 25 (depends on 22)

The method of derivatizing a polypeptide according to claim 22, wherein each of R1, R2, R3 and R4 are each deuterium.

### Claim 26 (depends on 22)

The method of derivatizing a polypeptide according to claim 22, wherein R1 and R2 are each alkyl.

### Claim 27 (depends on 22)

The method of derivatizing a polypeptide according to claim 22, wherein R1 and R2 are each independently a member selected from the group consisting of methyl, ethyl, propyl and butyl.

### Claim 28 (depends on 22)

The method of derivatizing a polypeptide according to claim 22, wherein R1 is an affinity tag.

### Claim 29

A method for mass spectrometric polypeptide analysis, said method comprising:
a) ionizing a modified polypeptide having a lysine residue of Formula I:
30
wherein each R is independently a member selected from the group consisting of hydrogen, deuterium, halogen, hydroxyl, cyano, optionally substituted alkyl, optionally substituted alkylcarbamoyl, optionally substituted alkoxy, optionally substituted alkoxycarbonyl, optionally substituted aryl, optionally substituted aryloxy, optionally substituted aryloxycarbonyl, optionally substituted arylcarbamoyl, optionally substituted siloxanyl, and an affinity tag;
mis0-7;and
wherein the circle joining the two nitrogens represents an optionally substituted monocyclic or bicyclic ring system having between 2 and 12 additional ring atoms, and wherein said ring atoms are each selected from the group consisting of carbon, oxygen, nitrogen, sulfur and silicon; and
b) analyzing the results of the ionized modified polypeptide.

### Claim 30 (depends on 29)

The method for mass spectrometric polypeptide analysis according to claim 29, wherein said modified polypeptide having a lysine residue of Formula I has Formula Ia:
31
wherein R1, R2, R3 and R4 are each independently a member selected from the group consisting of hydrogen, deuterium, halogen, hydroxyl, cyano, optionally substituted alkyl, optionally substituted alkylcarbamoyl, optionally substituted alkoxy, optionally substituted alkoxycarbonyl, optionally substituted aryl, optionally substituted aryloxy, optionally substituted aryloxycarbonyl, optionally substituted arylcarbamoyl and an affinity tag; or, alternatively, R2, R3 and the carbons to which they are attached join to form an n-membered carbocyclic, heterocyclic, aryl or heteroaryl ring;
wherein n is an integer from about 4 to about 8; and
R5is a member selected from the group consisting of hydrogen, halogen, hydroxyl, optionally substituted alkyl, optionally substituted alkoxy, and optionally substituted aryl, to form an ionized polypeptide.

### Claim 31 (depends on 30)

The method for mass spectrometric polypeptide analysis according to claim 30, wherein said modified polypeptide having a lysine residue of Formula I has Formula lb
32

### Claim 32 (depends on 30)

The method for mass spectrometric polypeptide analysis according to claim 30, wherein R1, R2, R3 and R4 are each hydrogen.

### Claim 33 (depends on 30)

The method for mass spectrometric polypeptide analysis according to claim 30, wherein R1, R2, R3 and R4 are each deuterium.

### Claim 34 (depends on 30)

The method for mass spectrometric polypeptide analysis according to claim 30, wherein R1 and R2 are each alkyl.

### Claim 35 (depends on 30)

The method for mass spectrometric polypeptide analysis according to claim 30, further comprising enzymatically digesting said modified polypeptide prior to step (a).

### Claim 36 (depends on 30)

The method for mass spectrometric polypeptide analysis according to claim 30, wherein R1 is an affinity tag, and said method further comprises purifying said modified polypeptide using said affinity tag prior to step (a).

### Claim 37 (depends on 30)

The method for mass spectrometric polypeptide analysis according to claim 30, wherein the ionization of step (a) comprises matrix-assisted desorption/ionization mass spectrometry.

### Claim 38 (depends on 30)

The method for mass spectrometric polypeptide analysis according to claim 30, wherein the ionization of step (a) comprises electrospray ionization mass spectrometry.

### Claim 39

A method for analyzing a sequentially labeled polypeptide, said method comprising:
incubating said polypeptide with a first label to form a first labeled polypeptide;
incubating said first labeled polypeptide with a second label to form a second labeled polypeptide, wherein at least one of said first label or said second label is a compound having Formula II:
33
wherein each R is independently a member selected from the group consisting of hydrogen, deuterium, halogen, hydroxyl, cyano, optionally substituted alkyl, optionally substituted alkylcarbamoyl, optionally substituted alkoxy, optionally substituted alkoxycarbonyl, optionally substituted aryl, optionally substituted aryloxy, optionally substituted aryloxycarbonyl, optionally substituted arylcarbamoyl and an affinity tag;
mis0-7;
wherein the circle joining the two nitrogens represents an optionally substituted monocyclic or bicyclic ring system having between 2 and 12 additional ring atoms, and wherein said ring atoms are each selected from the group consisting of carbon, oxygen, nitrogen, sulfur and silicon;
LG is a leaving group; and
analyzing said second labeled polypeptide with a mass spectrometer.

### Claim 40 (depends on 39)

The method for analyzing a sequentially labeled polypeptide according to claim 39, wherein said compound having Formula II, has Formula Ia
34
wherein R1, R2, R3 and R4 are each independently a member selected from the group consisting of hydrogen, deuterium, halogen, hydroxyl, cyano, optionally substituted alkyl, optionally substituted alkylcarbamoyl, optionally substituted alkoxy, optionally substituted alkoxycarbonyl, optionally substituted aryl, optionally substituted aryloxy, optionally substituted aryloxycarbonyl, optionally substituted arylcarbamoyl and an affinity tag; or, alternatively, R2, R3 and the carbons to which they are attached join to form an n-membered carbocyclic, heterocyclic, aryl or heteroaryl ring;
n is about 4 to about 8;
R5 is a member selected from the group consisting of hydrogen, halogen, hydroxyl, optionally substituted alkyl, optionally substituted alkoxy, optionally substituted aryl and an affinity tag;
LG is X-CH3, wherein X is a heteroatom selected from the groups consisting of O and S; and
y is 0, 1 or 2;

### Claim 41 (depends on 40)

The method for analyzing a sequentially labeled polypeptide according to claim 40, further comprising labeling said second labeled polypeptide with a third label to form a third labeled polypeptide.

### Claim 42 (depends on 40)

The method for analyzing a sequentially labeled polypeptide according to claim 40, wherein said first label, said second label and said third label are each independently selected from the group consisting of a compound of Formula II, and an amino acid specific label.

### Claim 43 (depends on 42)

The method for analyzing a sequentially labeled polypeptide according to claim 42, wherein said amino acid specific label is a member selected from the group consisting of a cysteine labeling reagent, an arginine label reagent and a carboxylic acid labeling reagent.

### Claim 44 (depends on 42)

The method for analyzing a sequentially labeled polypeptide according to claim 42, wherein said carboxylic acid reagent is an alcohol under esterifying conditions to form an ester.

### Claim 45 (depends on 42)

The method for analyzing a sequentially labeled polypeptide according to claim 42, wherein said high mass accuracy mass spectrometer is a Fourier transform ion cyclotron resonance spectrometer.

### Claim 46

A method for increasing the ionization efficiency of a lysine-containing polypeptide, said method comprising:
a) incubating a lysine-containing polypeptide with a compound of Formula II to form a modified polypeptide having a lysine residue of Formula I:
35
wherein each R is independently a member selected from the group consisting of hydrogen, deuterium, halogen, hydroxyl, cyano, optionally substituted alkyl, optionally substituted alkylcarbamoyl, optionally substituted alkoxy, optionally substituted alkoxycarbonyl, optionally substituted aryl, optionally substituted aryloxy, optionally substituted aryloxycarbonyl, optionally substituted arylcarbamoyl and an affinity tag;
mis0-7;and
wherein the circle joining the two nitrogens represents an optionally substituted monocyclic or bicyclic ring system having between 2 and 12 additional ring atoms, and wherein said ring atoms are each selected from the group consisting of carbon, oxygen, nitrogen, sulfir and silicon. and
b) ionizing said modified polypeptide having a lysine residue of Formula I, thereby increasing the ionization efficiency of said lysine-containing polypeptide.

### Claim 47 (depends on 46)

The method for increasing the ionization efficiency of a lysine-containing polypeptide according to claim 46, wherein said compound of Formula I has Formula Ia:
36
wherein R1, R2, R3 and R4 are each independently a member selected from the group consisting of hydrogen, deuterium, halogen, hydroxyl, cyano, optionally substituted alkyl, optionally substituted alkylcarbamoyl, optionally substituted alkoxy, optionally substituted alkoxycarbonyl, optionally substituted aryl, optionally substituted aryloxy, optionally substituted aryloxycarbonyl, optionally substituted arylcarbamoyl and an affinity tag; or, alternatively, R2, R3 and the carbons to which they are attached join to form an n-membered carbocyclic, heterocyclic, aryl or heteroaryl ring;
wherein n is an integer from about 4 to about 8; and
R5 is a member selected from the group consisting of hydrogen, halogen, hydroxyl, optionally substituted alkyl, optionally substituted alkoxy, and optionally substituted aryl, to form an ionized polypeptide.

### Claim 48 (depends on 47)

The method for increasing the ionization efficiency of a lysine-containing polypeptide according to claim 47, wherein said compound of Formula I has Formula Ib:
37

### Claim 49

A method for performing differential quantitation of a lysine-containing polypeptide, said method comprising:
a) incubating a first sample of a lysine-containing polypeptide with a first isotopic version of a compound of Formula II to form a first modified polypeptide having a lysine residue of Formula I:
38
wherein each R is independently a member selected from the group consisting of hydrogen, deuterium, halogen, hydroxyl, cyano, optionally substituted alkyl, optionally substituted alkylcarbamoyl, optionally substituted alkoxy, optionally substituted alkoxycarbonyl, optionally substituted aryl, optionally substituted aryloxy, optionally substituted aryloxycarbonyl, optionally substituted arylcarbamoyl, optionally substituted siloxanyl and an affinity tag;
m is 0-7; and
wherein the circle joining the two nitrogens represents an optionally substituted monocyclic or bicyclic ring system having between 2 and 12 additional ring atoms, and wherein said ring atoms are each selected from the group consisting of carbon, oxygen, nitrogen, sulfur and silicon;
b) incubating a second sample of said lysine-containing polypeptide with a second isotopic version of a compound of Formula II to form a second modified polypeptide having a lysine residue of Formula I;
c) combining said first sample and said second sample of said modified polypeptide having a lysine residue of Formula I to form a mixture; and
d) ionizing said mixture to form a series of isotopically labeled polypeptide pairs, wherein the relative concentrations of said first modified polypeptide having a lysine residue of Formula I and said second modified polypeptide having a lysine residue of Formula I are directly proportional to their relative signal intensities, and wherein the mass difference between the two modified polypeptides indicates the number of lysine(s) that are present in said lysine-containing polypeptide.

### Claim 50 (depends on 49)

The method for performing differential quantitation of a lysine-containing polypeptide according to claim 49, wherein said series of isotopically labeled polypeptide pairs indicates that at least two lysines are present.

### Claim 51 (depends on 49)

The method for performing differential quantitation of a lysine-containing polypeptide according to claim 49, wherein said first sample and said second sample of said lysine-containing polypeptides are combined in equal proportions.

### Claim 52

A method for determining the number of lysines in a lysine-containing polypeptide, said method comprising:
a) incubating a sample of a lysine-containing polypeptide with a first isotopic version of a compound of Formula II and a second isotopic version of a compound of Formula II to form a mixture having a first modified polypeptide having a lysine residue of Formula I and a second modified polypeptide having a lysine residue of Formula I, wherein Formula I has the formula:
39
wherein each R is independently a member selected from the group consisting of hydrogen, deuterium, halogen, hydroxyl, cyano, optionally substituted alkyl, optionally substituted alkylcarbamoyl, optionally substituted alkoxy, optionally substituted alkoxycarbonyl, optionally substituted aryl, optionally substituted aryloxy, optionally substituted aryloxycarbonyl, optionally substituted arylcarbamoyl, optionally substituted siloxanyl and an affinity tag;
mis0-7;and
wherein the circle joining the two nitrogens represents an optionally substituted monocyclic or bicyclic ring system having between 2 and 12 additional ring atoms, and wherein said ring atoms are each selected from the group consisting of carbon, oxygen, nitrogen, sulfur and silicon; and
b) ionizing said mixture to form a series of isotopically labeled polypeptide pairs, wherein the mass difference between said first modified polypeptide having a lysine residue of Formula I and said second modified polypeptide having a lysine residue of Formula I indicates the number of lysine(s) that are present in said lysine-containing polypeptide.

### Claim 53

The method for determining the number of lysines in a lysine-containing polypeptide according to 52, wherein said series of isotopically labeled polypeptide pairs indicates that at least two lysines are present.
